Search results for "analgesics"

showing 10 items of 260 documents

Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.

2008

The aim of this national cross-sectional survey was to draw information on pain prevalence and intensity from a large sample of patients who were admitted to oncologic centres for different reasons and to evaluate the pain treatment and possible influencing factors.A total of 2,655 patients completed the study. Nine hundred and one patients (34%) reported pain.Higher pain levels were observed in inpatients, in the presence of bone metastases, and with low levels of Eastern Cooperative Oncology Group status. The number of patients receiving strong opioids increased with the highest levels of pain. However, a significant part of patients with moderate-severe pain were not receiving appropriat…

AdultMalemedicine.medical_specialtySettore MED/06 - Oncologia MedicaCross-sectional studyPain medicineMEDLINEPainSeverity of Illness IndexNeoplasmsOncology Service HospitalEpidemiologySeverity of illnessmedicinePrevalenceHumansAgedAged 80 and overPrimary Health Carebusiness.industryCancer painEpidemiologyOpioidsNursing researchPhysicians FamilyMiddle AgedLarge sampleAnalgesics OpioidCross-Sectional StudiesOncologyItalyFamily medicineHealth Care SurveysPhysical therapyFemaleCancer painbusinessSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain

2015

Purpose: The aim of the present study was to assess the long-term tolerability and efficacy of intranasal fentanyl (INFS) in opioid-tolerant patients with breakthrough cancer pain (BTP).Patients and methods: A 6 months, observational, prospective, cohort study design was employed to follow advanced cancer patients with BTP receiving INFS under routine clinical practice. Eligible adult cancer patients suffering from BTP had been prescribed INFS at effective doses. Data were collected at T0 and at month intervals for six months. The principal outcomes were the evaluation of possible serious adverse effects with prolonged use of INFS, the efficacy of BTP treatment with INFS, the quality of sle…

AdultMalemedicine.medical_specialtySettore MED/42 - Igiene Generale E ApplicataFentanylCohort StudiesPatient satisfactionNeoplasmsInternal medicineparasitic diseasesHumansPain ManagementMedicineProspective StudiesCancer painAdverse effectProspective cohort studyAdministration IntranasalAgedPain Measurementbusiness.industryBreakthrough PainMiddle AgedTolerabilityDiscontinuationAnalgesics OpioidFentanylBreakthrough pain; Cancer pain; Intranasal fentanyl; Tolerability; OncologyOncologyTolerabilityPatient SatisfactionAnesthesiaIntranasal fentanylFemaleSleepbusinessCancer painmedicine.drugCohort studySupportive Care in Cancer
researchProduct

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.

2005

Patients who experience a poor response to different systemic opioid trials (oral and intravenous) are candidates for spinal treatment. Breakthrough pain occurring in this group of patients is challenging for physicians. This phenomenon has never been described in this context and the treatment is quite difficult, as patients already demonstrated a poor response to systemic opioids. We report a preliminary experience of alternative methods, including the intrathecal injection of local anesthetic boluses as needed, or alternatively, the use of sublingual ketamine. Twelve consecutive patients with advanced cancer and pain were selected for intrathecal treatment after receiving different trial…

AdultMalemedicine.medical_specialtymedicine.drug_classPopulationAnalgesicAdministration SublingualPainNeoplasmsmedicineHumansKetamineAnesthetics LocaleducationGeneral NursingInjections SpinalAgedLevobupivacaineeducation.field_of_studyAnalgesicsbusiness.industryLocal anestheticMiddle AgedBupivacaineSurgeryAnesthesiology and Pain MedicineLevobupivacaineOpioidAnesthesiaMorphineFemaleKetamineNeurology (clinical)businessCancer painmedicine.drugJournal of pain and symptom management
researchProduct

Typical trigeminal neuralgia by an atypical compression: case report and review of the literature.

2014

Aim Trigeminal neuralgia is a disabling form of facial pain that causes a considerable discomfort and a marked reduction in the quality of life. Although neurovascular compression is often associated with trigeminal neuralgia, other intracranial pathologies can result in compression along the nerve. Case description The authors report a case of a patient suffering from a typical left trigeminal neuralgia affecting both the second and the third branches. Neuroradiological examinations showed the presence of an arachnoid cyst located in the left temporal lobe, contiguous with the Meckel's cave, eroding the greater wing of the sphenoid bone. Following a meticulous decision-making process the p…

AdultMalemedicine.medical_specialtytypical trigeminal neuralgiaSphenoid bonePainMagnetic resonance angiographyArachnoid cystTrigeminal neuralgiaSphenoid BonemedicineHumansCranial nerve diseaseArachnoid cyst; Conservative treatment; Trigeminal neuralgia; Adult; Analgesics Non-Narcotic; Carbamazepine; Cranial Nerve Diseases; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Nerve Compression Syndromes; Pain; Sphenoid Bone; Treatment Outcome; Trigeminal Neuralgia; Neurology (clinical); SurgeryPathologicalmedicine.diagnostic_testbusiness.industrySettore MED/27 - NeurochirurgiaNerve Compression SyndromesCarbamazepineAnalgesics Non-NarcoticTrigeminal Neuralgiamedicine.diseaseMagnetic Resonance ImagingCranial Nerve Diseasesnervous system diseasesSurgeryNerve compression syndromebody regionsCarbamazepineTreatment OutcomeSurgeryNeurology (clinical)medicine.symptombusinessMagnetic Resonance Angiographymedicine.drug
researchProduct

Efficacy and side effects of intravenous remifentanil patient-controlled analgesia used in a stepwise approach for labour: an observational study

2012

Remifentanil has a suitable pharmacological profile for labour analgesia. In this prospective, observational study, intravenous patient-controlled analgesia with remifentanil, using stepwise bolus doses without background infusion, was examined during the first and second stages of labour. Outcomes were pain reduction, maternal satisfaction, maternal and neonatal side effects and remifentanil metabolism in the neonate.Parturients with normal term singleton pregnancies were recruited. The initial remifentanil bolus dose was 0.15 μg/kg, increasing in steps of 0.15 μg/kg, with a 2-min lock-out. Pain scores using a 100 mm visual analogue scale, systolic and diastolic blood pressures, respirator…

AdultRespiratory rateVisual analogue scalemedicine.medical_treatmentSedationRemifentanilBlood PressureRemifentanilYoung AdultBolus (medicine)PiperidinesHeart RatePregnancymedicineHumansPain ManagementProspective StudiesMaternal-Fetal ExchangePain MeasurementLabor PainLabor ObstetricPatient-controlled analgesiabusiness.industryInfant NewbornObstetrics and GynecologyAnalgesia Patient-ControlledAnalgesics OpioidTreatment OutcomeAnesthesiology and Pain MedicinePatient SatisfactionAnesthesiaApgar ScoreAnalgesia ObstetricalFemaleApgar scoremedicine.symptombusinessmedicine.drugIntravenous Patient-Controlled AnalgesiaInternational Journal of Obstetric Anesthesia
researchProduct

The association between intrapartum opioid fentanyl and early breastfeeding: A prospective observational study

2021

Introduction: Intrapartum opioids in labor may interfere with the early breastfeeding phase and cause breastfeeding difficulties. This study examines the effects of intrapartum fentanyl given intravenously (IV) or through epidural analgesia (EDA) on early breastfeeding. Material and methods: This is a prospective observational study conducted in a regional maternity unit. We included 1101 healthy mothers of term singleton babies in vertex presentation born between 2016 and 2018 (468 nulliparous and 633 multiparous). The main data were collected prospectively, and additional data were retrieved from hospital records. The main outcome measures were exclusive breastfeeding at discharge, sponta…

Adultmedicine.medical_specialtyTime FactorsBreastfeedingMedical RecordsFentanylRoute of administrationPregnancySurveys and QuestionnairesHumansMedicineLabor analgesiaProspective StudiesPain MeasurementLabor Painbusiness.industryObstetricsObstetrics and GynecologyGeneral MedicineOdds ratioAnalgesics OpioidFentanylVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gynekologi og obstetrikk: 756Breast FeedingOpioidFemaleBreastfeeding difficultiesObservational studybusinessmedicine.drugActa Obstetricia et Gynecologica Scandinavica
researchProduct

Resectoscope versus small diameter hysteroscopy for endometrial polypectomy in patients with "unfavorable" cervix

2017

BACKGROUND: The aim of this study was to compare resectoscopic and small-diameter hysteroscopic techniques for endometrial polypectomy in patients with "unfavorable" cervix.METHODS: Eighty women with a single 2-4 cm sized endometrial polyp, with unfavorable cervical anatomical conditions were enrolled in the study. Forty patients were treated with a 26F resectoscope requiring cervical dilatation (group A), forty patients were treated with a 5-mm hysteroscope requiring vaginoscopic approach (group B). Operative time, fluid absorption, complications, instrument failure, postoperative pain, overnight stay were analyzed. Operative visualization, operative difficulty and overall surgeon's satisf…

Adultmedicine.medical_specialtyVisual analogue scalemedicine.medical_treatmentOperative TimeCervix UteriHysteroscopyGroup Blaw.inventionEndometriumPolypsRandomized controlled triallawmedicineEndometrial PolypHysteroscopesHumansCervical canalCervixAgedAnalgesicsPain Postoperativemedicine.diagnostic_testbusiness.industryObstetrics and GynecologyMiddle AgedSettore MED/40 - Ginecologia E OstetriciaPolypectomySurgeryEndometrial Neoplasmsmedicine.anatomical_structureHysteroscopyFemalebusinessComplication
researchProduct

Quality of life and disability of chronic non-cancer pain in adults patients attending pain clinics: A prospective, multicenter, observational study

2020

What do we already know about this subject? • Chronic pain can have negative effects on quality of life. It is associated with a reduced ability to work, quality of life and disability, conditions that should be treated in specialized pain management clinics. In Italy very little information on clinical outcomes after chronic pain treatments is provided. What does our study add to the already existing information • This study is the first to provide clinical data about the impact of chronic pain in terms of quality of life and disability on patients who attended pain management clinics in Italy. • Chronic pain has a negative impact on quality of life and disability and causes presenteeism. …

Adultmedicine.medical_specialtybusiness.industryNon cancerMEDLINESettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheAnalgesics OpioidQuality of life (healthcare)Pain ClinicsnursingdisabilityQuality of LifePhysical therapyHumansPain ClinicsMedicineObservational studyProspective StudiesChronic PainbusinessGeneral NursingApplied Nursing Research
researchProduct

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects

2021

Accumulation of senescent cells may drive age-associated alterations and pathologies. Senolytics are promising therapeutics that can preferentially eliminate senescent cells. Here, we performed a high-throughput automatized screening (HTS) of the commercial LOPAC®Pfizer library on aphidicolin-induced senescent human fibroblasts, to identify novel senolytics. We discovered the nociceptin receptor FQ opioid receptor (NOP) selective ligand 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole (MCOPPB, a compound previously studied as potential anxiolytic) as the best scoring hit. The ability of MCOPPB to eliminate senescent cells in in vitro models was further tested…

Agingmedicine.drug_classNarcotic AntagonistsNOPMCOPPBSenescenceLigandsAnxiolyticMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePiperidinesSenotherapeuticsOpioid receptormedicineAnimalsHumansSenolyticCaenorhabditis elegansReceptorSenolyticCellular Senescence030304 developmental biology0303 health sciencesNOPSenolytic.ChemistryLigand (biochemistry)High-Throughput Screening Assays3. Good healthCell biologyAnalgesics OpioidNociceptin receptorAnti-Anxiety AgentsOpioid PeptidesReceptors OpioidOriginal ArticleGeriatrics and Gerontology030217 neurology & neurosurgeryGeroScience
researchProduct

Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.

2011

Background Preclinical data implicate the reinforcing effects of alcohol to be mediated by interaction between the opioid and dopamine systems of the brain. Specifically, alcohol-induced release of β-endorphins stimulates μ-opioid receptors (MORs), which is believed to cause dopamine release in the brain reward system. Individual differences in opioid or dopamine neurotransmission have been suggested to be responsible for enhanced liability to abuse alcohol. In the present study, a single dose of the MOR agonist remifentanil was administered in detoxified alcohol-dependent patients and healthy control subjects to mimic the β-endorphin-releasing properties of ethanol and to assess the effect…

AgonistAdultMaleFluorine RadioisotopesPyrrolidinesmedicine.drug_classDopamineReceptors Opioid muPharmacologySeverity of Illness IndexRemifentanilRadioligand AssayDopamine receptor D1PiperidinesDopamine receptor D3DopaminemedicineLimbic SystemHumansBiological PsychiatryReceptors Dopamine D2PutamenFunctional NeuroimagingVentral striatumAlcohol dependenceMiddle AgedAnalgesics OpioidBehavior AddictiveAlcoholismmedicine.anatomical_structurenervous systemFallypridePositron-Emission TomographyBenzamidesPsychologymedicine.drugBiological psychiatry
researchProduct